The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 21.70
Bid: 21.70
Ask: 21.85
Change: -0.10 (-0.46%)
Spread: 0.15 (0.691%)
Open: 21.00
High: 22.10
Low: 21.00
Prev. Close: 21.80
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity - Exercise of ESOP Options

22 Aug 2023 07:00

RNS Number : 0542K
Atlantic Lithium Limited
22 August 2023
 

 

 

22 August 2023

Directors DealingsIssue of Equity - Exercise of ESOP Options

The Board of Atlantic Lithium Limited (AIM: ALL, ASX: A11, OTCQX: ALLIF, "Atlantic Lithium" or the "Company"), the African-focused lithium exploration and development company targeting to deliver Ghana's first lithium mine, wishes to advise the allotment and issue of 3,000,000 ordinary shares of no par value each in the Company ("Ordinary Shares") at a price of 30 pence per share as a result of the exercise of unlisted ESOP options which were granted on 18 August 2021 to Len Kolff and held in the name of a person closely associated ("PCA") of Mr Kolff.

A PCA of Len Kolff, Head of Business Development & Chief Geologist, has acquired 3,000,000 new Ordinary Shares at a price of 30p each as a result of the exercise of ESOP options, for a total consideration of £900,000.

Application will be made for the total 3,000,000 Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to take place on or around 30 August 2023.

Following Admission, the beneficial shareholdings of the Directors will be as follows:

Director / PDMR Role

Current number of Ordinary Shares held

% of Share Capital

Neil Herbert

7,638,892

1.25

Amanda Harsas

4,200,000

0.68

Len Kolff

6,180,852

1.01

Patrick Brindle

108,000

0.02

Keith Muller

-

-

Kieran Daly

-

-

Christelle van der Merwe

-

-

Total

18,127,744

2.96

 

On Admission of the 3,000,000 Ordinary Shares to trading, the issued share capital of the Company will comprise 612,241,660 Ordinary Shares. When calculating voting rights, shareholders should use this figure as the denominator for the calculations by which they determine if they are required to notify their interest in, or change in their interest in, the share capital of the Company.

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

 

ISSUE OF ORDINARY SHARES

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Melisa Kolff van Oosterwijk

2.

Reason for the notification

a)

Position/status:

PCA of Lennard Kolff van Oosterwijk, Head of Business Development & Chief Geologist

b)

Initial notification/Amendment:

Initial notification 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Atlantic Lithium Limited 

b)

LEI:

213800H1JY3J7BB6BN06

4.

1. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of no par value

ISIN: AU0000237554

b)

Nature of the transaction:

Exercise of ESOP Options

 

c)

Price(s) and volume(s):

 Price(s)

Volume(s)

30p

 

3,000,000

 

 

d)

Aggregated information:

 

Single transaction as in 4 c) above

 Price(s)

Volume(s)

30p

 

3,000,000

 

 

 

e)

Date of the transaction:

22 August 2023

f)

Place of the transaction:

Outside of a trading venue

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

 

For any further information, please contact:

Atlantic Lithium Limited

Neil Herbert (Executive Chairman)

Amanda Harsas (Finance Director and Company Secretary)

www.atlanticlithium.com.au

IR@atlanticlithium.com.au

Tel: +61 2 8072 0640

 

SP Angel Corporate Finance LLP

Nominated Adviser

Jeff Keating

Charlie Bouverat

Tel: +44 (0)20 3470 0470

Yellow Jersey PR Limited

Charles Goodwin

Bessie Elliot atlantic@yellowjerseypr.com

Tel: +44 (0)20 3004 9512

 

Canaccord Genuity Limited

Company Broker

Raj Khatri / James Asensio

Harry Rees

Tel: +44 (0) 20 7523 4500

 

Notes to Editors:

 

About Atlantic Lithium

www.atlanticlithium.com.au

Atlantic Lithium is an AIM and ASX-listed lithium company advancing a portfolio of lithium projects in Ghana and Côte d'Ivoire through to production.

The Company's flagship project, the Ewoyaa Project in Ghana, is a significant lithium spodumene pegmatite discovery on track to become Ghana's first lithium-producing mine. The Company signed a funding agreement with Piedmont Lithium Inc. towards the development of the Ewoyaa Project. Atlantic Lithium is currently advancing the Ewoyaa Project through feasibility studies and intends to be producing a spodumene concentrate via simple gravity only process flowsheet.

Atlantic Lithium holds 560km2 and 774km2 of tenure across Ghana and Côte d'Ivoire respectively, comprising significantly under-explored, highly prospective licences.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOENKBBNQBKKPFB
Date   Source Headline
15th Oct 20149:47 amRNSForm 8.3 - Allocate Software plc
15th Oct 20149:47 amRNSForm 8.3 - [Allocate Software]
15th Oct 20149:21 amRNSForm 8.5 (EPT/RI)
14th Oct 20145:37 pmRNSForm 8.3 - Allocate Software PLC
14th Oct 20142:13 pmRNSFURTHER IRREVOCABLE UNDERTAKING RECEIVED
14th Oct 201411:17 amRNSForm 8 (OPD) (Acorn Bidco Limited)
14th Oct 201410:58 amRNSForm 8.3 - Allocate Software Plc
14th Oct 201410:10 amRNSReplacement Form 8 (OPD) Offeree
14th Oct 20147:06 amRNSForm 8 (OPD) Offeree
14th Oct 20147:02 amRNSRecommended Cash Offer for Allocate Software plc
26th Sep 20147:00 amRNSNew Chief Financial Officer Appointment
23rd Sep 20148:36 amRNSHolding(s) in Company
2nd Sep 20146:01 pmRNSDividend Notification
26th Aug 201410:00 amRNSFurther Amendments To Long Term Retention Plan
22nd Jul 20142:19 pmRNSHolding(s) in Company
21st Jul 20147:01 amRNSAllocate Share Options Schemes
21st Jul 20147:00 amRNSFinal Results
17th Jul 20143:55 pmRNSHolding(s) in Company
16th Jun 20147:00 amRNSTrading Update
5th Jun 20147:00 amRNSProduct Launch
9th May 20142:35 pmRNSBlocklisting Interim Review
9th May 20142:30 pmRNSBlock Listing Review
8th May 20147:00 amRNSContract Win
17th Mar 20147:00 amRNSGrant of Share Options to Directors
21st Feb 201410:56 amRNSHolding(s) in Company
21st Feb 201410:52 amRNSExercise of Share Options & Director Shareholdings
13th Feb 201412:00 pmRNSDirectorate Change
30th Jan 20147:00 amRNSContract Win
20th Jan 20147:00 amRNSInterim Results
9th Jan 20144:56 pmRNSHolding(s) in Company
16th Dec 20137:00 amRNSTrading Update
4th Dec 201312:56 pmRNSHolding(s) in Company
4th Dec 20139:00 amRNSHolding(s) in Company
28th Nov 20137:00 amRNSBoard Appointment
26th Nov 20133:27 pmRNSResult of AGM and Scrip Dividend Scheme
14th Nov 20135:34 pmRNSScrip Dividend Scheme
6th Nov 20137:00 amRNSDirector/PDMR Shareholding
4th Nov 20134:50 pmRNSBlocklisting Application
4th Nov 201311:28 amRNSDirector/PDMR Shareholding
4th Nov 201310:06 amRNSNotification of Major Interest in Shares
4th Nov 20139:29 amRNSChange of Registered Office
4th Nov 20137:00 amRNSNotification of Major Interest in Shares
28th Oct 20133:15 pmRNSDirector/PDMR Shareholding
25th Oct 20139:15 amRNSNotification of Major Interest in Shares
21st Oct 20132:17 pmRNSNotice of AGM
21st Oct 20137:00 amRNSNotification of Major Interest in Shares
8th Oct 20133:24 pmRNSDirector/PDMR Shareholding
8th Oct 201311:39 amRNSNotification of Major Interest in Shares
7th Oct 20137:11 amRNSNotification of Major Interest in Shares
7th Oct 20137:00 amRNSBlocklisting Application

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.